Terauchi Gaku, Shinoda Kei, Yagura Kazuma, Kawashima Makoto, Matsumoto Soiti Celso, Mizota Atsushi, Miyake Yozo
School of Medicine, Teikyo University, Tokyo 173-8606, Japan.
Faculty of Medicine, Saitama Medical University, Saitama 350-0495, Japan.
J Clin Med. 2022 Oct 29;11(21):6404. doi: 10.3390/jcm11216404.
Purpose: The purpose of this study was to determine the effect of brilliant blue G (BBG) staining of the inner limiting membrane (ILM) on macular function. Method: Fourteen eyes of 14 patients consisting of 9 men and 5 women who underwent vitreous surgery with ILM peeling were studied. The mean age of the patients was 68.8 ± 9.14 years. Three eyes had a macular hole and eleven eyes had an epiretinal membrane. The ILM was made more visible by spraying 0.25% BBG into the vitreous cavity. The macular function was assessed by recording intraoperative focal macular electroretinograms (iFMERGs) before and after the intravitreal spraying of the BBG dye. The iFMERGs were recorded three times after core vitrectomy. The first recording was performed before the BBG injection (Phase 1, baseline), the second recording was performed after the spraying of the BBG and washing out the excess BBG (Phase 2), and the third recording was performed after the ILM peeling (Phase 3). All recordings were performed after 5 min of light-adaptation and stabilization of the intraocular conditions. The iFMERGs were recorded twice at each phase. The implicit times and amplitudes of the a- and b-wave, the PhNR, and the d-wave were measured. Wilcoxon signed-rank test were used to determine the significance of differences of the findings at Phase 2 vs. Phase 1 and Phase 3 vs. Phase 1. A p value < 0.05 was taken to be statistically significant. Results: The average implicit times of the a-wave, b-wave, PhNR, and d-wave were not significantly different in Phase 1, 2, and 3. The average a-wave, b-wave, PhNR, and d-wave amplitudes at Phase 1 did not differ significantly from that at Phase 2 and at Phase 3. Conclusions: The results indicated that the intravitreal injection of BBG does not alter the physiology of the macula, and we conclude that BBG is safe. We also conclude that iFMERGs can be used to monitor the macular function safely during intraocular surgery.
本研究旨在确定内界膜(ILM)的亮蓝G(BBG)染色对黄斑功能的影响。方法:对14例患者的14只眼睛进行了研究,其中男性9例,女性5例,均接受了玻璃体手术并进行了ILM剥除。患者的平均年龄为68.8±9.14岁。3只眼睛有黄斑裂孔,11只眼睛有视网膜前膜。通过向玻璃体腔喷洒0.25%的BBG使ILM更易于观察。通过记录玻璃体腔内喷洒BBG染料前后的术中局灶性黄斑视网膜电图(iFMERGs)来评估黄斑功能。在核心玻璃体切除术后iFMERGs记录3次。第一次记录在注射BBG之前(阶段1,基线)进行,第二次记录在喷洒BBG并冲洗掉多余的BBG之后(阶段2)进行,第三次记录在ILM剥除之后(阶段3)进行。所有记录均在光适应5分钟且眼内情况稳定后进行。每个阶段iFMERGs记录2次。测量a波和b波、视网膜负向反应(PhNR)和d波的潜伏时间和振幅。采用Wilcoxon符号秩检验来确定阶段2与阶段1以及阶段3与阶段1的结果差异的显著性。p值<0.05被认为具有统计学意义。结果:阶段1、2和3中a波、b波、PhNR和d波的平均潜伏时间无显著差异。阶段1的平均a波、b波、PhNR和d波振幅与阶段2和阶段3相比无显著差异。结论:结果表明玻璃体腔内注射BBG不会改变黄斑的生理功能,我们得出结论BBG是安全的。我们还得出结论,iFMERGs可用于在眼内手术期间安全地监测黄斑功能。